NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,457 | +0.9% | 299 | 0.0% | 0.02% | +5.6% |
| Q2 2023 | $30,173 | +64.0% | 299 | +49.5% | 0.02% | +50.0% |
| Q1 2023 | $18,400 | +1.4% | 200 | 0.0% | 0.01% | -7.7% |
| Q4 2022 | $18,144 | +21.0% | 200 | 0.0% | 0.01% | +18.2% |
| Q3 2022 | $15,000 | -11.8% | 200 | 0.0% | 0.01% | -8.3% |
| Q2 2022 | $17,000 | -5.6% | 200 | 0.0% | 0.01% | +9.1% |
| Q1 2022 | $18,000 | +5.9% | 200 | 0.0% | 0.01% | +22.2% |
| Q4 2021 | $17,000 | +6.2% | 200 | 0.0% | 0.01% | -10.0% |
| Q3 2021 | $16,000 | -11.1% | 200 | 0.0% | 0.01% | -9.1% |
| Q2 2021 | $18,000 | +5.9% | 200 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $17,000 | -10.5% | 200 | 0.0% | 0.01% | -21.4% |
| Q4 2020 | $19,000 | +11.8% | 200 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $17,000 | 0.0% | 200 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $17,000 | +6.2% | 200 | 0.0% | 0.02% | -15.8% |
| Q1 2020 | $16,000 | -15.8% | 200 | 0.0% | 0.02% | +5.6% |
| Q4 2019 | $19,000 | – | 200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |